In NPC, the anti-cancer HIF-1α is not usually expressed, while HIF-2α, a transcriptional regulator with oncogenic effects, regulates downstream processes involved in angiogenesis, glucose metabolism, and tumor growth target genes (35, 36). The gene discussed is HIF1A; the disease is neoplasm.